News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Ferrante Karen Jean
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 2,345 options to buy
@ $9.55, valued at
$22.4k
|
|
| 07/05/2023 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 1,884 options to buy
@ $11.96, valued at
$22.5k
|
|
| 06/08/2023 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 36,700 options to buy
@ $11.7, valued at
$429.4k
|
|
| 06/02/2023 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on MACROGENICS INC|
Txns:
| Granted 19,000 options to buy
@ $4.67, valued at
$88.7k
Granted 4,500 restricted stock units
@ $0 |
|
| 01/04/2023 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 1,862 options to buy
@ $11.07, valued at
$20.6k
|
|
| 10/04/2022 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 1,474 options to buy
@ $14.33, valued at
$21.1k
|
|
| 07/05/2022 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 2,279 options to buy
@ $9.39, valued at
$21.4k
|
|
| 06/09/2022 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 30,700 options to buy
@ $4.59, valued at
$140.9k
|
|
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2022 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 2,753 options to buy
@ $7.92, valued at
$21.8k
|
|
| 01/04/2022 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 2,329 options to buy
@ $8.7, valued at
$20.3k
|
|
| 10/05/2021 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 2,385 options to buy
@ $8.54, valued at
$20.4k
|
|
| 07/06/2021 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 2,513 options to buy
@ $8.02, valued at
$20.2k
|
|
| 05/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2021 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 2,121 options to buy
@ $9.08, valued at
$19.3k
|
|
| 03/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 1,575 options to buy
@ $7.6191, valued at
$12k
|
|
| 10/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2020 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on Unum Therapeutics Inc.|
Txns:
| Granted 14,331 options to buy
@ $0.63, valued at
$9k
|
|
| 05/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/08/2020 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on Unum Therapeutics Inc.|
Txns:
| Granted 54,422 options to buy
@ $0.3495, valued at
$19k
|
|
| 01/06/2020 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on Unum Therapeutics Inc.|
Txns:
| Granted 26,480 options to buy
@ $0.72, valued at
$19.1k
|
|
| 10/03/2019 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on Unum Therapeutics Inc.|
Txns:
| Granted 13,646 options to buy
@ $1.41, valued at
$19.2k
|
|
| 07/15/2019 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC|
Txns:
| Granted 25,000 options to buy
@ $5.74, valued at
$143.5k
|
|
| 07/03/2019 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on Unum Therapeutics Inc.|
Txns:
| Granted 6,199 options to buy
@ $2.41, valued at
$14.9k
|
|
| 06/20/2019 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on Unum Therapeutics Inc.|
Txns:
| Granted 14,331 options to buy
@ $2.7, valued at
$38.7k
|
|
| 05/20/2019 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on MACROGENICS INC|
Txns:
| Granted 10,000 options to buy
@ $18, valued at
$180k
Granted 4,616 options to buy
@ $18, valued at
$83.1k
|
|
| 04/03/2019 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on Unum Therapeutics Inc.|
Txns:
| Granted 4,047 options to buy
@ $4.4, valued at
$17.8k
|
|
| 01/04/2019 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on Unum Therapeutics Inc.|
Txns:
| Granted 4,073 options to buy
@ $4.47, valued at
$18.2k
|
|
| 10/03/2018 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on Unum Therapeutics Inc.|
Txns:
| Granted 1,769 options to buy
@ $10.37, valued at
$18.3k
|
|
| 09/26/2018 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on Unum Therapeutics Inc.|
Txns:
| Granted 1,261 options to buy
@ $14.57, valued at
$18.4k
|
|
| 06/14/2018 |
4
| Ferrante Karen Jean (Director) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC|
Txns:
| Granted 25,000 options to buy
@ $8.99, valued at
$224.8k
|
|
|
|
|